{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:45:40Z","timestamp":1792532740724,"version":"4.5.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T00:00:00Z","timestamp":1611619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","award":["CVON 2011\/ B019, CVON 2017-20, 2020T029, 2017T048, 2007T067, 2010B022, 2015B002, 2019B016"],"award-info":[{"award-number":["CVON 2011\/ B019, CVON 2017-20, 2020T029, 2017T048, 2007T067, 2010B022, 2015B002, 2019B016"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001674","name":"Fondation Leducq","doi-asserted-by":"publisher","award":["transatlantic network grant"],"award-info":[{"award-number":["transatlantic network grant"]}],"id":[{"id":"10.13039\/501100001674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Macrophages define a key component of immune cells present in atherosclerotic lesions and are central regulators of the disease. Since epigenetic processes are important in controlling macrophage function, interfering with epigenetic pathways in macrophages might be a novel approach to combat atherosclerosis. Histone H3K27 trimethylation is a repressive histone mark catalyzed by polycomb repressive complex with EZH2 as the catalytic subunit. EZH2 is described to increase macrophage inflammatory responses by supressing the suppressor of cytokine signaling, <jats:italic>Socs3<\/jats:italic>. We previously showed that myeloid deletion of <jats:italic>Kdm6b<\/jats:italic>, an enzymes that in contrast to EZH2 removes repressive histone H3K27me3 marks, results in advanced atherosclerosis. Because of its opposing function and importance of EZH2 in macrophage inflammatory responses, we here studied the role of myeloid EZH2 in atherosclerosis. A myeloid-specific <jats:italic>Ezh2<\/jats:italic> deficient mouse strain (<jats:italic>Ezh2<\/jats:italic><jats:sup>del<\/jats:sup>) was generated (LysM-cre+ x <jats:italic>Ezh2<\/jats:italic><jats:sup>fl\/fl<\/jats:sup>) and bone marrow from <jats:italic>Ezh2<\/jats:italic><jats:sup>del<\/jats:sup> or <jats:italic>Ezh2<\/jats:italic><jats:sup>wt<\/jats:sup> mice was transplanted to <jats:italic>Ldlr<\/jats:italic><jats:sup>-\/-<\/jats:sup> mice which were fed a high fat diet for 9 weeks to study atherosclerosis. Atherosclerotic lesion size was significantly decreased in <jats:italic>Ezh2<\/jats:italic><jats:sup>del<\/jats:sup> transplanted mice compared to control. The percentage of macrophages in the atherosclerotic lesion was similar, however neutrophil numbers were lower in <jats:italic>Ezh2<\/jats:italic><jats:sup>del<\/jats:sup> transplanted mice. Correspondingly, the migratory capacity of neutrophils was decreased in <jats:italic>Ezh2<\/jats:italic><jats:sup>del<\/jats:sup> mice. Moreover, peritoneal <jats:italic>Ezh2<\/jats:italic><jats:sup>del<\/jats:sup> foam cells showed a reduction in the inflammatory response with reduced production of nitric oxide, IL-6 and IL-12. In Conclusion, myeloid <jats:italic>Ezh2<\/jats:italic> deficiency impairs neutrophil migration and reduces macrophage foam cell inflammatory responses, both contributing to reduced atherosclerosis.<\/jats:p>","DOI":"10.3389\/fimmu.2020.594603","type":"journal-article","created":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T14:41:05Z","timestamp":1611672065000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Myeloid Ezh2 Deficiency Limits Atherosclerosis Development"],"prefix":"10.3389","volume":"11","author":[{"given":"Annette E.","family":"Neele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Jen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion J. J.","family":"Gijbels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"van der Velden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marten A.","family":"Hoeksema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke C. S.","family":"Boshuizen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Van den Bossche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton T.","family":"Tool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanke L.","family":"Matlung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo K.","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Lutgens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menno P. J.","family":"de Winther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,1,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrcardio.2009.228","article-title":"Monocytes in atherosclerosis: subsets and functions","volume":"7","author":"Woollard","year":"2010","journal-title":"Nat Rev Cardiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ejphar.2015.03.101","article-title":"Epigenetic pathways in macrophages emerge as novel targets in atherosclerosis","volume":"763","author":"Neele","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0000000000000109","article-title":"Macrophage polarization: the epigenetic point of view","volume":"25","author":"Van den Bossche","year":"2014","journal-title":"Curr Opin Lipidol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.2669","article-title":"Transcriptional regulation by Polycomb group proteins","volume":"20","author":"Di Croce","year":"2013","journal-title":"Nat Struct Mol Biol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1035902","article-title":"Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein","volume":"16","author":"Kuzmichev","year":"2002","journal-title":"Genes Dev"},{"key":"B6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0092-8674(02)00976-5","article-title":"Histone methyltransferase activity of a Drosophila Polycomb group repressor complex","volume":"111","author":"Muller","year":"2002","journal-title":"Cell"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2008.11.004","article-title":"Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms","volume":"32","author":"Margueron","year":"2008","journal-title":"Mol Cell"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00172","article-title":"Regulation of T Cell Differentiation and Function by EZH2","volume":"7","author":"Karantanos","year":"2016","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20180479","article-title":"Repressing the repressor: Ezh2 mediates macrophage activation","volume":"215","author":"Neele","year":"2018","journal-title":"J Exp Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20171417","article-title":"Macrophage\/microglial Ezh2 facilitates autoimmune inflammation through inhibition of Socs3","volume":"215","author":"Zhang","year":"2018","journal-title":"J Exp Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1101\/gad.186056.111","article-title":"The histone H3 Lys 27 demethylase JMJD3 regulates gene expression by impacting transcriptional elongation","volume":"26","author":"Chen","year":"2012","journal-title":"Genes Dev"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2009.271","article-title":"Jmjd3 contributes to the control of gene expression in LPS-activated macrophages","volume":"28","author":"De Santa","year":"2009","journal-title":"EMBO J"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.08.019","article-title":"The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing","volume":"130","author":"De Santa","year":"2007","journal-title":"Cell"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-04-217620","article-title":"Epigenetic regulation of the alternatively activated macrophage phenotype","volume":"114","author":"Ishii","year":"2009","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nature11262","article-title":"A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response","volume":"488","author":"Kruidenier","year":"2012","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1920","article-title":"The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection","volume":"11","author":"Satoh","year":"2010","journal-title":"Nat Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2014.03.025","article-title":"Jmjd3-mediated epigenetic regulation of inflammatory cytokine gene expression in serum amyloid A-stimulated macrophages","volume":"26","author":"an","year":"2014","journal-title":"Cell Signal"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2018.05.052","article-title":"Myeloid Kdm6b deficiency results in advanced atherosclerosis","volume":"275","author":"Neele","year":"2018","journal-title":"Atherosclerosis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.molcel.2008.10.016","article-title":"EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency","volume":"32","author":"Shen","year":"2008","journal-title":"Mol Cell"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-11-3940","article-title":"Neutrophils in Barth syndrome (BTHS) avidly bind annexin-V in the absence of apoptosis","volume":"103","author":"Kuijpers","year":"2004","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.06.054","article-title":"Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses","volume":"151","author":"Spann","year":"2012","journal-title":"Cell"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008942828960","article-title":"Conditional gene targeting in macrophages and granulocytes using LysMcre mice","volume":"8","author":"Clausen","year":"1999","journal-title":"Transgenic Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jim.2014.05.009","article-title":"Comparative analysis of the efficiency and specificity of myeloid-Cre deleting strains using ROSA-EYFP reporter mice","volume":"408","author":"Abram","year":"2014","journal-title":"J Immunol Methods"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/embo-reports\/kve064","article-title":"A highly efficient ligand-regulated Cre recombinase mouse line shows that LoxP recombination is position dependent","volume":"2","author":"Vooijs","year":"2001","journal-title":"EMBO Rep"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157265","article-title":"Histone Methyltransferase Enhancer of Zeste Homolog 2-Mediated ABCA1 Promoter DNA Methylation Contributes to the Progression of Atherosclerosis","volume":"11","author":"Lv","year":"2016","journal-title":"PloS One"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-019-0326-7","article-title":"Neutrophils as regulators of cardiovascular inflammation","volume":"17","author":"Silvestre-Roig","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.961714","article-title":"Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis","volume":"122","author":"Drechsler","year":"2010","journal-title":"Circulation"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1182\/blood.V122.21.1556.1556","article-title":"Functional Defects In Neutrophils Derived From Ezh2 Null Mice","volume":"122","author":"Perez-Ladaga","year":"2013","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3125","article-title":"The methyltransferase Ezh2 controls cell adhesion and migration through direct methylation of the extranuclear regulatory protein talin","volume":"16","author":"Gunawan","year":"2015","journal-title":"Nat Immunol"},{"key":"B30","volume-title":"Macrophage regulatory mechanisms in atherosclerosis: the interplay of lipids and inflammation. [PhD thesis]","author":"Neele","year":"2018"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.594603\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T14:41:11Z","timestamp":1611672071000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.594603\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,26]]},"references-count":30,"alternative-id":["10.3389\/fimmu.2020.594603"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.594603","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,26]]},"article-number":"594603"}}